OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Equity and the JAMA Network	646
The Gut Microbiome in Melanoma: A Piece of a Complex Puzzle	338
Widespread Erythematous Plaques With Prominent Telangiectases	295
JAMA Dermatology	195
Dermatomyositis	147
Progressive Skin Depressions in a Child’s Neck	132
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	127
Multiple Painless Subcutaneous Nodules on the Cheek of an Immunocompetent Man	119
Melanoma Overdiagnosis Is Not the Key Problem—Reply	112
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	109
Error in Author Byline	109
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil	93
Error in Author Name	92
Association Between Gender-Affirming Hair Removal and Mental Health Outcomes	90
JAMA Dermatology Peer Reviewers in 2021	90
Treatment of Warts With Needle-Free Injection of Fluorouracil	81
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	76
What Are We Waiting for?—Start Screening High-risk Individuals for Anal Cancer Now—Reply	74
Use of Dupilumab and Eosinophil Targeted Therapy in Treating Angiolymphoid Hyperplasia With Eosinophilia	72
Cutaneous Lupus Erythematosus of the Vulvar Skin	70
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis	67
Association Between Melanoma Detected During Routine Skin Checks and Mortality	67
Alopecia Areata	66
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma—Reply	65
Pruritic Rash in a Woman With Endometrial Cancer	64

JAMA Dermatology	64
JAMA Dermatology	59
Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease	57
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	55
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	53
JAMA Dermatology	50
Treatment-Resistant Edematous Annular Plaques and Mild Leukopenia in a Man in His 60s	50
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	48
Nutritional Supplements and Hair Loss—Limitations to the Interpretation of Clinical Studies Before Implementation in Clinical Practice	48
JAMA Dermatology	47
Eosinophilic Granulomatosis With Polyangiitis	47
Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib	46
Assessment of Cutaneous Vasculitis and Quality of Life	46
Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat	45
Follow-up of Patients With Keratinocyte Carcinoma	43
Painful Mucosal Ulcerations in a Patient With HIV	42
Multiple Yellowish Plaques in a Cobblestone Pattern on the Tongue	42
Errors in Figure 2	42
An Asymptomatic Verrucous Plaque on the Right Temple of an Adolescent Girl	42
SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma	40
Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	39
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	39
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	38
Double Standards and Inconsistencies in Access to Care—What Constitutes a Cosmetic Treatment?	37
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	37
Generalized Micropapular Eruption in a Teenager	37
Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic	36
Pseudofolliculitis Barbae	36
Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit	36
JAMA Dermatology	35
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	35
Macrocheilia as an Atypical Clinical Presentation of Capillary Malformation–Arteriovenous Malformation Type 2	34
Favre-Racouchot Syndrome	34
Olmsted Syndrome	34
Molluscum Contagiosum Therapeutics—New Options May Be Around the Corner	33
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	32
Cutaneous Stigmata of Bacterial Endocarditis	32
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	31
Pigmentary Changes in a Woman With Oral Lichen Planus	31
Progressive Papular Eruption of the Distal Upper Extremities in a Patient With Asymptomatic Papules	31
Errors in Abstract, Results, Tables, and Figures	31
Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1	31
The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa	31
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis	30
Comorbidities in Korean Patients With Palmoplantar Pustulosis vs Psoriasis Vulgaris or Pompholyx	30
Clinical Features and Outcomes of Black Patients With Melanoma	30
Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship	30
Melanoma Screening	30
Association of Survival With Immune-Related Adverse Events—Time to Consider the Duration of Treatment	30
Firm Red-Brown Plaques in a Patient With Systemic Scleroderma	30

Skin Cancer Care in US Veterans—Serving Those Who Served	29
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	29
Ecchymotic Plaques on the Scalp of a Man in His 80s	29
Error in Author Surname in Byline	29
Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC)—Keeping Solid Organ Transplant Recipients on Track for Skin Cancer Screening	28
Credibility and Generalization of the Minimally Important Difference Concept in Dermatology	28
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	28
Perceptions of US-Based Muslim Patients of Their Dermatology Care	28
Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use	28
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	27
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children	27
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US	27
Prurigo Nodularis	27
Efficacy of Therapies for Actinic Keratosis	26
Autoreactivity to BP180 Neoepitopes in Patients With Pemphigoid Gestationis	26
Error in the Results Section	26
Single-Lesion Skin Cancer Risk Stratification Triage Pathway	26
Nail Sarcoidosis	26
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency	26
Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States	26
Multiple Umbilicated Papules on the Face	25
Barber Knowledge and Recommendations for Pseudofolliculitis Barbae	24
Clinical Settings and Demographic Characteristics of Patients With Sunburn	24
Challenging the Tools Used to Measure Cutaneous Lupus Severity in Patients of All Skin Types	24
Fast-Growing Frontal Subcutaneous Nodule in a Young Woman	24
Importance of LGBTQ+–Inclusive Language When Developing and Selecting Patient-Reported Outcome Measures	24
Annular Eroded Plaque With Honey-Colored Crusting On Scrotum	24
Amending the Pain Scale Used for Postoperative Pain Studies—Reply	24
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis	24
Ultraprocessed Food Intake and Psoriasis	24
Psoriasis Risk With Immune Checkpoint Inhibitors	24
Melanoma Tumor Mutational Burden and Indoor Tanning Exposure	23
Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus	23
Methotrexate and Interstitial Lung Disease	23
Salt and Atopic Dermatitis	23
JAMA Dermatology	22
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	22
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	22
The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products	22
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	22
Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years	22
Evaluation of Pharmacologic Treatments for H₁ Antihistamine–Refractory Chronic Spontaneous Urticaria	22
Development and Initial Validation of a Novel System to Assess Ichthyosis Severity	21
Biosimilars in Dermatology	21
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	21
An Enlarging Painless Nodule on a Man’s Index Finger	21
Risk Prediction Models for Sentinel Node Positivity in Melanoma	21
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome	21
Blistering Lesions Associated With Loncastuximab Tesirine	21
Latine Patients’ Beliefs, Attitudes, and Experience With Psoriasis	21
Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus	21
JAMA Dermatology	21
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases	21
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant	20
Cooling Research Fever in Dermatology—The Role of Community Service	20
Need for Consideration of Patient-Specific Risk Factors in Step Therapy	20
Clinical Management of Neuropathic Itch	20
JAMA Dermatology	20
Tinea Nigra Palmaris	19
Keratosis Pilaris–Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma	19
Trichomegaly Due to Panitumumab	19
Coxsackievirus A6–Induced Atypical Hand-Foot-Mouth Disease	19
Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development	19
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab	19
JAMA Dermatology	19
Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum	18
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	18
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	18
Patient-Reported Outcomes in Dermatology	18
Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma	18
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	18
Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients—The High-Risk Balancing Act	18
Telangiectases in Systemic Sclerosis	18
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	18
Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial Mucositis	18
Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups	18
Tuberculous Mastitis	17
Calcitonin Gene-Related Peptide Inhibition and Development of Acne and Rosacea	17
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	17
JAMA Dermatology	17

Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	17
Advances in Melanoma-Nevus Classification Using Artificially Generated Image Data Sets	17
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	17
Depression and Anxiety in Patients With Lichen Sclerosus	17
Association of Body Lice Infestation With Hemoglobin Values in Hospitalized Dermatology Patients	17
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis	16
Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children	16
Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea	16
Pyoderma Gangrenosum	16
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	16
Long-term Outcomes and Prognosis in New-Onset Psoriasis	16
Antibiotic Stewardship in Dermatology—Reducing the Risk of Prolonged Antimicrobial Resistance in Skin	16
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	16
Genetic Variants Associated With Hidradenitis Suppurativa	16
Cutaneous Angiosarcoma	16
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	16
Differences in Skin Cancer Rates by Transplanted Organ Type and Patient Age After Organ Transplant in White Patients	16
Cutaneous Intestinal Metaplasia With Adenocarcinoma Treated With Intralesional Fluorouracil	16
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema)	15
Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood	15
Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne	15
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	15
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	15
Errors in the Discussion Section and Supplement 1	15
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis	15
Errors in Figures 1 and 3	15
Oral Acitretin Plus Topical Triamcinolone vs Topical Triamcinolone Monotherapy in Patients With Symptomatic Oral Lichen Planus	15
Introducing the JAMA Dermatology Editorial Fellowship	15
Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa	15
Sunburn Injuries Admitted to Burn Services in Australia and New Zealand	15
The Global Prevalence of Seborrheic Dermatitis	14
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	14
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma	14
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	14
Machine Learning–Based Deep Phenotyping of Atopic Dermatitis	14
Subtype and Racial Erythema Variation for Cutaneous Lupus Trials	14
Comparison of Work Relative Value Units for Outpatient Pediatric and Adult Dermatology Encounters	14
External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort	14
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss	14
Characterizing Epidemiology and Burden of Disease in Alopecia Areata—Making It Count	13
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice	13
Anatomic Subtype Differences in Extramammary Paget Disease	13
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis	13
Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users	13
Best Practices for Sharing Images in Clinical Care, Research, and Education—Protecting Patient Privacy	13
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level	13
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	13
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment	13
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus	13
High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population	13
Janus Kinase Inhibitors and Adverse Events of Acne	13
Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population	13
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images	13
Quantitative Sensory Testing to Characterize Sensory Changes in Hidradenitis Suppurativa Skin Lesions	12
Error in Box	12
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients	12
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	12
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population	12
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	12
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	12
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary	11
Treatment of Kimura Disease With Dupilumab	11
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome	11
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis	11
Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo	11
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders	11
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)	11
Efficacy and Safety of Topical Nitric Oxide−Releasing Berdazimer Gel in Patients With Molluscum Contagiosum	11
Patient-Relevant Outcomes in Psoriasis	11
Apremilast in Recalcitrant Cutaneous Dermatomyositis	11
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	11
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	11
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	11
Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis	11
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	11
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary	10
Evaluation of Dupilumab in Patients With Bullous Pemphigoid	10
Foscarnet-Induced Penile Ulceration	10
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	10
Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts	10
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis	10
Efficacy of Therapies for Actinic Keratosis—Reply	10
Acquired Melanocytic Nevi Mimicking Acral Lentiginous Melanoma in a Patient Taking a BRAF Inhibitor	10
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	10
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	10
Error in Corresponding Author’s Address	10
Extravasation of Iodine Contrast	9
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	9
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	9
More Than Skin Deep—Understanding the Lived Experience of Acne	9
Indurated Plaques With Telangiectasias on the Lower Limbs	9
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	9
Multiple Itchy Erythematous Papules and Plaques Localized to 1 Shin	9
Progressive Generalized Skin Laxity in a Young Woman	9
Radiologic Imaging for High-Stage Cutaneous Squamous Cell Carcinomas	9